Sun Pharma.Inds.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE044A01036
  • NSEID: SUNPHARMA
  • BSEID: 524715
INR
1,990.50
-10.6 (-0.53%)
BSENSE

Jul 31, 03:30 PM

BSE+NSE Vol: 51.06 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
239.93
239.93
239.93
239.93
239.93
239.93
Share Warrants & Outstandings
Total Reserve
83,330.16
71,978.09
63,426.82
55,755.45
47,771.29
46,222.85
Shareholder's Funds
83,570.09
72,218.02
63,666.75
55,995.38
48,011.22
46,462.78
Minority Interest
309.65
267.93
3,459.19
3,320.09
3,054.89
3,017.05
Long-Term Borrowings
31.26
2.52
1.33
0.00
229.92
654.71
Secured Loans
0.00
0.00
0.00
0.00
0.00
7.83
Unsecured Loans
31.26
2.52
1.33
0.00
229.92
646.88
Deferred Tax Assets / Liabilities
-3,668.44
-4,215.11
-3,931.79
-3,487.23
-2,817.72
-3,511.93
Other Long Term Liabilities
1361.98
760.42
802.86
1147.14
902.36
1014.93
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
512.18
465.04
413.89
342.91
369.07
327.12
Total Non-Current Liabilities
-1,763.02
-2,987.13
-2,714.34
-1,997.80
-1,316.37
-1,515.17
Current Liabilities
Trade Payables
7,333.80
6,184.34
5,653.30
5,681.52
4,489.76
3,973.66
Other Current Liabilities
5,293.83
3,987.63
3,128.55
2,672.60
2,870.10
4,720.54
Short Term Borrowings
4,050.35
1,867.11
2,844.36
6,197.88
700.77
2,868.78
Short Term Provisions
5,944.06
6,155.13
5,357.56
5,354.38
9,147.82
4,582.65
Total Current Liabilities
22,622.04
18,194.21
16,983.77
19,906.38
17,208.45
16,145.63
Total Liabilities
1,04,738.76
87,693.03
81,396.00
77,224.67
66,958.19
64,110.29
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
60,321.41
45,949.61
44,320.48
43,099.95
38,707.36
35,578.99
Less: Accumulated Depreciation
27,499.14
23,363.33
21,072.33
19,034.51
16,042.20
14,026.01
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
32,822.27
22,586.28
23,248.15
24,065.44
22,665.16
21,552.98
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
1,380.65
1,234.34
1,107.73
963.35
797.51
936.52
Intangible assets under development
1,671.08
5,409.62
4,246.15
4,009.81
489.29
630.31
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
3,789.07
4,697.70
6,441.23
5,451.73
5,214.65
6,482.39
Long Term Loans & Advances
1,135.51
1,076.94
2,844.94
2,835.99
2,924.26
4,061.34
Other Non Current Assets
79.89
94.09
74.69
36.41
2.72
4.67
Total Non-Current Assets
40,878.47
35,098.97
37,962.89
37,362.73
32,093.59
33,668.21
Current Assets Loans & Advances
Current Investments
20,933.45
13,656.10
8,584.54
9,372.61
7,633.94
3,130.06
Inventories
11,492.93
10,243.33
9,868.29
10,513.05
8,925.13
8,997.02
Sundry Debtors
15,509.67
13,046.11
11,249.37
11,438.51
10,484.59
9,061.40
Cash and Bank
11,603.08
11,331.62
10,520.68
5,770.29
5,033.35
6,445.51
Other Current Assets
798.82
978.87
1,192.78
960.13
852.83
1,186.91
Short Term Loans and Advances
3,676.34
3,492.03
2,067.45
1,857.35
1,934.76
1,621.18
Total Current Assets
63,860.29
52,594.06
43,433.11
39,861.94
34,864.60
30,442.08
Net Current Assets (Including Current Investments)
41,238.25
34,399.85
26,449.34
19,955.56
17,656.15
14,296.45
Total Current Assets Excluding Current Investments
42,926.84
38,937.96
34,848.57
30,489.33
27,230.66
27,312.02
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
1,04,738.76
87,693.03
81,396.00
77,224.67
66,958.19
64,110.29
Contingent Liabilities
2,066.73
8,434.44
5,172.73
4,361.77
3,773.19
4,714.13
Total Debt
4,081.61
1,869.63
2,845.69
6,197.88
930.69
3,523.49
Book Value per share (adjusted)
348.31
301
265.36
233.38
200.11
193.65
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2026 is 118.31% vs -34.30% in Mar 2025

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2026 is 79.11% vs -5.29% in Mar 2025

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2026 is 43.59% vs -2.20% in Mar 2025

stock-summary

Investments

YoY Growth in year ended Mar 2026 is -19.34% vs -27.07% in Mar 2025

stock-summary

Current Assets

YoY Growth in year ended Mar 2026 is 21.42% vs 21.09% in Mar 2025

Compare Balance Sheet Results of Sun Pharma.Inds.
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
239.93
53.00
186.93
352.70%
Share Warrants & Outstandings
Total Reserve
83,330.16
16,708.00
66,622.16
398.74%
Shareholder's Funds
83,570.09
16,761.00
66,809.09
398.60%
Minority Interest
309.65
0.00
309.65
0.00%
Long-Term Borrowings
31.26
0.00
31.26
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
31.26
0.00
31.26
0.00%
Deferred Tax Assets / Liabilities
-3,668.44
455.00
-4,123.44
-906.25%
Other Long Term Liabilities
1,361.98
679.00
682.98
100.59%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
512.18
81.00
431.18
532.32%
Total Non-Current Liabilities
-1,763.02
1,215.00
-2,978.02
-245.10%
Current Liabilities
Trade Payables
7,333.80
1,211.00
6,122.80
505.60%
Other Current Liabilities
5,293.83
772.00
4,521.83
585.73%
Short Term Borrowings
4,050.35
0.00
4,050.35
0.00%
Short Term Provisions
5,944.06
60.00
5,884.06
9,806.77%
Total Current Liabilities
22,622.04
2,043.00
20,579.04
1,007.30%
Total Liabilities
1,04,738.76
20,019.00
84,719.76
423.20%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
60,321.41
9,401.00
50,920.41
541.65%
Less: Accumulated Depreciation
27,499.14
2,880.00
24,619.14
854.83%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
32,822.27
6,521.00
26,301.27
403.33%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
1,380.65
2,113.00
-732.35
-34.66%
Intangible assets under development
1,671.08
0.00
1,671.08
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
3,789.07
69.00
3,720.07
5,391.41%
Long Term Loans & Advances
1,135.51
204.00
931.51
456.62%
Other Non Current Assets
79.89
9.00
70.89
787.67%
Total Non-Current Assets
40,878.47
8,923.00
31,955.47
358.12%
Current Assets Loans & Advances
Current Investments
20,933.45
0.00
20,933.45
0.00%
Inventories
11,492.93
3,954.00
7,538.93
190.67%
Sundry Debtors
15,509.67
2,984.00
12,525.67
419.76%
Cash and Bank
11,603.08
3,414.00
8,189.08
239.87%
Other Current Assets
798.82
282.00
516.82
183.27%
Short Term Loans and Advances
3,676.34
462.00
3,214.34
695.74%
Total Current Assets
63,860.29
11,096.00
52,764.29
475.53%
Net Current Assets (Including Current Investments)
41,238.25
9,053.00
32,185.25
355.52%
Total Current Assets Excluding Current Investments
42,926.84
11,096.00
31,830.84
286.87%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
1,04,738.76
20,019.00
84,719.76
423.20%
Contingent Liabilities
2,066.73
8.00
2,058.73
25,734.12%
Total Debt
4,081.61
0.00
4,081.61
0.00%
Book Value per share (adjusted)
348.31
632.49
-284.18
-44.93%
Annual - Borrowings
Borrowings 4,081.61 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 118.31% vs -34.30% in Mar 2025

Annual - Other Long Term Liabilities
Other Long Term Liabilities 1,361.98 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 79.11% vs -5.29% in Mar 2025

Annual - Fixed Assets
Fixed Assets 34,202.92 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 43.59% vs -2.20% in Mar 2025

Annual - Investments
Investments 3,789.07 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -19.34% vs -27.07% in Mar 2025

Annual - Current Assets
Current Assets 63,860.29 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 21.42% vs 21.09% in Mar 2025